EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.24.60 | (19-28)ANF peptide + H2O |
i.e. atrial natriuretic factor derived peptide, cleavage site: Gly20-Leu21 |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (20-28)ANF peptide + H2O |
i.e. atrial natriuretic factor derived peptide |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (21-28)ANF octapeptide + H2O |
i.e. atrial natriuretic factor derived peptide |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (22-28)ANF heptapeptide + H2O |
i.e. atrial natriuretic factor derived peptide |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (23-28)ANF hexapeptide + H2O |
i.e. atrial natriuretic factor derived peptide |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (5-11)Substance P heptapeptide + H2O |
i.e. Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2, cleavage site: Gly9-Leu10 |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (5-28)ANF + H2O |
- |
Xenopus laevis |
ANF(5-25) + Phe26-Arg27-Tyr28 |
- |
? |
3.4.24.60 | (5-28)ANF + H2O |
i.e. atrial natriuretic factor, cleavage site: exclusively Ser25-Phe26 |
Xenopus laevis |
ANF(5-25) + Phe26-Arg27-Tyr28 |
- |
? |
3.4.24.60 | (6-11)Substance P hexapeptide + H2O |
i.e. Gln-Phe-Phe-Gly-Leu-Met-NH2, cleavage site: Gly9-Leu10 |
Xenopus laevis |
? |
- |
? |
3.4.24.60 | (Arg0,Leu6)-enkephalin + H2O |
cleavage of Phe4-Leu5 |
Xenopus laevis |
? |
- |
? |